Evidence map›Paper›PMID 39850257›Full record

ArticleJournal of arthropod-borne diseases2024

Development and Optimization of a Nanoparticle-Based Imidacloprid Insecticide for Effective Control of

Ismail Saba, Amir Amani, Mojgan Baniardalani, Hamid Reza Basseri

Abstract read
In one paragraph

Article in Journal of arthropod-borne diseases, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Ismail SabaDepartment of Vector Biology and Control of Diseases, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.
Amir AmaniNatural Products and Medicinal Plants Research Center, North Khorasan University of Medical Sciences, Bojnurd, Iran.
Mojgan BaniardalaniDepartment of Vector Biology and Control of Diseases, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.
Hamid Reza BasseriDepartment of Vector Biology and Control of Diseases, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The German cockroach ( Methods: A bioassay was conducted to determine the LC Results: A comparison of the bioassay results for nanoencapsulated and imidacloprid technical revealed a superior insecticidal effect of the nanoencapsulated imidacloprid against the German cockroach. The LC Conclusion: The use of nanotechnology in insecticides can lead to increased efficacy and reduced consumption. This is because the smaller particle size of nanomaterials allows for better penetration and targeted delivery to pest organisms, reducing the overall amount needed for control.

Indexed as

German cockroachImidaclopridInsecticideNanoparticle

Identifiers

PMID39850257
PMCPMC11752672

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.